Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FFFQW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,180
Award facts
- Contract value 100% obligated
- $48,179.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $48,179.57 delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Wegovy 1 mg/0.5 ml pens with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains a comprehensive federal contract portfolio supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive experience delivering medications across multiple therapeutic domains—including diabetes treatments, neurological medications, pain management pharmaceuticals, and specialized medical supplies—demonstrates its capability to fulfill federal medical procurement requirements. This delivery order for Wegovy, a GLP-1 receptor agonist medication, aligns with the company's established role as a critical vendor supporting the Defense Health Agency and other federal healthcare systems through DLA's pharmaceutical prime vendor programs.
Quick answers
Who was awarded contract SPE2DB26FFFQW?
SPE2DB26FFFQW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FFFQW worth?
The government has obligated $48,180 on SPE2DB26FFFQW.
Is contract SPE2DB26FFFQW an order under another contract?
Yes. SPE2DB26FFFQW is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB26FFFQW competed?
The extent of competition for SPE2DB26FFFQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award